Delgado-Calle Jesus
Researcher
Also affiliated: Winthrop Rockefeller Foundation (2026); Indiana University School of Medicine (2019); Indiana University – Purdue University Indianapolis (2019)
Graduate Student Researcher
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Research by Jesus Delgado-Calle focuses on the molecular mechanisms of multiple myeloma, particularly targeting the Notch3 receptor to overcome therapy resistance and eliminate dormant cancer cells. His work has contributed to understanding how Notch3 signaling influences the survival and persistence of multiple myeloma cells, even after treatment. This research involves the use of various cellular and animal models to investigate potential therapeutic strategies. Delgado-Calle collaborates with researchers at the University of Arkansas for Medical Sciences, including Japneet Kaur, Elena Ambrogini, C. Lowry Barnes, and Jeffrey B. Stambough, with whom he has co-authored publications.
Metrics
- Publications: 2
Selected Publications
-
Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells (2026)
Collaboration Network
Top Collaborators
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
Similar Researchers
Based on overlapping research topics